758718-51-3

Basic information

• Product Name: (2α,3β)- 2-(Acetyloxy)-3-hydroxy- olean-12-en-28-oic acid
• Synonyms: (2α,3β)- 2-(Acetyloxy)-3-hydroxy- olean-12-en-28-oic acid;(2alpha,3beta)- 2-(Acetyloxy)-3-hydroxy- olean-12-en-28-oic acid
• CAS NO: 758718-51-3
• Molecular Formula: C32H50 O5
• Molecular Weight: 0
• Product Categories: Pentacyclic Triterpenes
• Mol File: 758718-51-3.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (2α,3β)- 2-(Acetyloxy)-3-hydroxy- olean-12-en-28-oic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (2α,3β)- 2-(Acetyloxy)-3-hydroxy- olean-12-en-28-oic acid(758718-51-3)
• EPA Substance Registry System: (2α,3β)- 2-(Acetyloxy)-3-hydroxy- olean-12-en-28-oic acid(758718-51-3)

Safety Data

• Hazardous Substances Data: 758718-51-3(Hazardous Substances Data)

Usage

Description

(2α,3β)2-(Acetyloxy)-3-hydroxyolean-12-en-28-oic acid is a triterpenoid compound that is a derivative of oleanolic acid, a naturally occurring substance found in many plants. This specific compound is distinguished by the presence of an acetyloxy group at position 2 and a hydroxyl group at position 3 on the olean-12-en-28-oic acid structure. These structural modifications can influence the biological activities and pharmacological properties of the parent compound, making it a promising candidate for drug discovery and development.

Uses

Used in Pharmaceutical Industry:
(2α,3β)2-(Acetyloxy)-3-hydroxyolean-12-en-28-oic acid is used as a potential therapeutic agent for various conditions due to its anti-inflammatory, anti-cancer, and anti-diabetic properties. Its structural modifications may enhance the efficacy and selectivity of the compound, making it a valuable asset in drug development.
Used in Drug Discovery:
(2α,3β)2-(Acetyloxy)-3-hydroxyolean-12-en-28-oic acid is utilized in the field of natural product chemistry and pharmacology for the discovery of new drugs. Its unique structure and potential biological activities make it an interesting target for research and development, with the aim of creating novel therapeutic agents for a range of diseases.